Company Filing History:
Years Active: 2003-2007
Title: Ralf Broermann: Innovator in Protein Composition Technologies
Introduction
Ralf Broermann is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of protein compositions, particularly in the production of pharmaceutical preparations. With a total of 2 patents, his work has implications for medical and therapeutic applications.
Latest Patents
Ralf Broermann's latest patents include innovative methods for producing preparations based on fibrinogen and fibronectin. The first patent describes a method for producing protein compositions that involves treating a fibrinogen and fibronectin-containing starting solution with a precipitating composition. This composition modifies the solubility of fibrinogen and/or fibronectin, resulting in a single-step precipitation that forms a precipitate containing both proteins. The precipitate can then be further treated using established methods.
The second patent outlines a method for producing fibronectin and fibrinogen compositions using a polyalkylene glycol and glycine or β-alanine. This method involves admixing a precipitating composition into a starting solution of fibrinogen and fibronectin, leading to the formation of a precipitate. The pharmaceutical preparation derived from this precipitate has a specific fibronectin:fibrinogen ratio, enhancing its therapeutic potential.
Career Highlights
Ralf Broermann is currently associated with Baxter Aktiengesellschaft, a leading company in the healthcare sector. His work at Baxter focuses on advancing protein-based therapies, contributing to the development of innovative medical solutions. His expertise in protein chemistry and formulation has positioned him as a key player in his field.
Collaborations
Ralf collaborates with Thomas Seelich, leveraging their combined expertise to drive advancements in protein composition technologies. Their partnership enhances the research and development efforts at Baxter, fostering innovation in pharmaceutical preparations.
Conclusion
Ralf Broermann's contributions to the field of protein compositions through his patents and work at Baxter Aktiengesellschaft highlight his role as an influential inventor. His innovative methods for producing pharmaceutical preparations have the potential to impact medical treatments significantly.